BAX Fair Value Estimate
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.

Baxter International Inc
Every day, Baxter and the Baxter Foundation strive to make a meaningful difference in the lives of people who depend on our products, and in the communities where our employees live and work. The Foundation helps advance Baxter's Mission to Save and Sustain Lives by partnering with organizations around the world to increase access to healthcare for the underserved, develop the next generation of innovators who will lead the way in advancing healthcare and create a positive, long-lasting impact in communities globally. For more information, please visit Baxter's Corporate Responsibility page. Baxter is a registered trademark of Baxter International Inc. or its subsidiaries. i Carey, Ben, et al., 2022, PLOS One ii Kline et al., 2020, Academic Emergency Medicine SOURCE Pet Partners
Free cash flow has been growing at -21.8% annually.
Current Price
$16.68
-0.60%GoodMoat Value
$50.11
200.4% undervaluedBased on the GoodMoat target price of $50.11, Baxter International appears deeply undervalued, offering a theoretical margin of safety of over 190%. However, this assessment is complicated by the company's current negative profitability metrics and high debt, which require careful scrutiny of the underlying assumptions for the target price.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Graham Number, PEG-based, and Earnings-based models
View Fair Value →Baxter International Inc (BAX) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The GoodMoat Fair Value target for Baxter International Inc is $50.11. The current stock price is $16.68, suggesting the stock is 200.4% undervalued.
The price-to-earnings (P/E) ratio is -8.96. Price-to-book ratio is 1.40. Price-to-sales ratio is 0.76. Enterprise value to EBITDA is 24.82. PEG ratio is -0.07.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Baxter International Inc's intrinsic value.